Influence of PEG chain length on in vitro drug release and in vivo pharmacokinetics of hydroxycamptothecin(HCPT) loaded PEG-PHDCA niosomes

Bin SHI,Chao FANG,Mei-xian YOU,Yuan-ying PEI
DOI: https://doi.org/10.3321/j.issn:1001-2494.2005.21.014
2005-01-01
Abstract:OBJECTIVE To investigate the influence of PEG chain length on in vitro and in vivo behaviors of Hydroxycamptothecin (HCPT) loaded PEG-PHDCA niosomes. METHODS PEG-PHDCA niosomes were prepared by film-dispersion and hydration-sonication method and lyophilized. The niosomes were further characterized in terms of structure, particle size, drug loading coeffiecint, drug encapsulation rate, in vitro drug release and in vivo pharmacokinetics. RESULTS The parameters of drug loading coeffiecint, in vitro drug release and in vivo Pharmacokinetics were proved to be related to PEG chain length. When PEG MW incresed from 2000 to 10000, the drug loading coefficient decreased from 3.04% to 1.99%. The in vitro drug release was fitted well by Higuchi equation and the drug release was accelerated with the PEG chain length. The plasma concentration-time curve of HCPT was fitted by a two compartment open model. The niosomes of PEGPHDCA with PEG chain length of 2000, 5000 and 10000 prolonged the half life of HCPF in plasma from 0.72 h to 7.17, 11.46 and 6.39 h(P0.001), respectively; while AUCs were 8.40, 24.50 and 6.24-fold of that of HCPT(P0.001), respectively. CONCLUSION PEG5000-PHDCA niosomes show a sustained release pattern in vitro and best stability effect in vivo.
What problem does this paper attempt to address?